Pharmaceutical

Phenylketonuria (PKU) Treatment Market :- Ajinomoto Cambrooke, American Gene Technologies, Ultragenyx Pharmaceutical, Danone Nutricia , Reckitt Benckiser Group plc

Phenylketonuria (PKU) Treatment Market

The Phenylketonuria (PKU) Treatment Market report offers key parts of the business with the subtleties of the effect and Pharmaceutical industry specialists keep up a reliable review with inventive patterns, offer and cost. It offers a flat-out examination of the Pharmaceutical industry in a joined stage which is grounds on various fragments including key areas, item/administration types, and applications, innovation and so forth. An appraisal of the effect of current market patterns and conditions is additionally included to give data on future market extension. The report gives itemized data on the future effect of different guidelines received by government in different divisions of the Phenylketonuria (PKU) Treatment Market.

Global Phenylketonuria (PKU) Treatment Market is rising at substantial CAGR in the forecast period of 2019-2026. This rise in market can be attributed to increasing incidence rate of phenylketonuria, growing research in the field of genomics and biotechnology, increasing awareness about the phenylketonuria, change in lifestyle of the people, rising per capita income in emerging markets and development in the health care industry.

Phenylketonuria (PKU) Treatment Market research report gives specific analysis for the quickly changing elements of the Pharmaceutical business. The primary goal of this Phenylketonuria (PKU) Treatment report is to comprehend the future standpoint and prospect of the Pharmaceutical Industry. Talented market researchers examines the entire market scenario and have helped to form this first class Phenylketonuria (PKU) Treatment report and they have performed inside-out data social affair practices on a tremendous scale premise. The Phenylketonuria (PKU) Treatment research report additionally gives detail investigation on the flow applications and relative examination with progressively centered on the upstream and downstream of focused market.

Request for FREE Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-phenylketonuria-pku-treatment-market

Market Definition: Global Phenylketonuria (PKU) Treatment Market 

Phenylketonuria is a rare inherited genetic disorder that leads to the increase in levels of phenylalanine in blood. Phenylalanine is an amino acid which is comprised of proteins obtained from food and diet. Phenylalanine hydroxylase enzyme converts phenylalanine in to tyrosine amino acid in human body. The tyrosine is required to create neurotransmitters, such as epinephrine, norepinephrine and dopamine in human body. Phenylketonuria is caused due to a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of this enzyme leads to a buildup of phenylalanine in the body and starts getting stored in the blood stream and consequently, damaging the brain. The patient of phenylketonuria can develop symptoms such as seizures, skin conditions, tremors or trembling and shaking, hyperactivity, stunted growth and more.

The incidence of phenylketonuria is approximately 1 in 10,000 in European populations, although it is less common in the African-American population, with an incidence of approximately 1 in 50,000. Phenyketonuria is rare in Finland and Japan, although its incidence may vary markedly between different regions.

Market Drivers

Increasing incidence rate of phenylketonuria is driving the market growth

Increasing awareness amongst the people is enhancing the market growth

Growing research in the field of genomics and bioinformatics is flourishing the market growth

Changing lifestyle is encouraging the market growth

Advancements in the health care industry and rising per capita income in emerging markets

Market Restraints

Overall high cost of treatment is hampering the market growth

Stringent government regulations is hindering the market growth

Unfavorable reimbursement is acting as a restraint for the market growth

Lack of awareness among the patient and physician about Phenylketonuria is a hindering factor for the market growth

Segmentation: Global Phenylketonuria (PKU) Treatment Market 

By Type

Hyperphenylalaninemia

Mild PKU

Moderate or Variant

Classic PKU

By Drug Type

Kuvan

Sapropterin

Palynziq

Pagvaliase

Biopten

By Therapy Type

Gene Therapy

Dietary Therapy

By Route of Administration

Oral

Intravenous

Subcutaneous

By End-Users

Hospitals

Homecare

Specialty Clinics

Others

By Geography

North America

S.

Canada

Mexico

South America

Brazil

Argentina

Rest of South America

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Turkey

Belgium

Netherlands

Switzerland

Rest of Europe

Asia-Pacific

Japan

China

South Korea

India

Australia

Singapore

Thailand

Malaysia

Indonesia

Philippines

Rest of Asia Pacific

Middle East & Africa

South Africa

Egypt

Saudi Arabia

United Arab Emirates

Israel

Rest of Middle East & Africa

Browse Full Report with Details TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-phenylketonuria-pku-treatment-market

Key Developments in the Market:

  • In May 2019, BioMarin received approval from the European Commission for Palynziq (pegvaliase injection) for the treatment of phenylketonuria (PKU) in patients. This drug is able to offer this important new therapy to the adults with PKU who are unable to control their [phenylalanine] levels with existing options
  • In May 2017, BioMarin received approval from FDA for pegvaliase-pqpz (Palynziq), a drug for the treatment of phenylketonuria (PKU) in patients. This drug is able to offer this important new therapy to adults with PKU who are unable to control their [phenylalanine] levels with existing options

Speak to Our Analyst for more Details:- https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-phenylketonuria-pku-treatment-market

Competitive Analysis: Global Phenylketonuria (PKU) Treatment Market 

Global phenylketonuria (PKU) treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global phenylketonuria (PKU) treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players: Global Phenylketonuria (PKU) Treatment Market 

Few of the major competitors currently working in the global phenylketonuria (PKU) treatment market are  DAIICHI SANKYO COMPANY, LIMITED,  Ajinomoto Cambrooke, Inc., American Gene Technologies, Inc., Ultragenyx Pharmaceutical, Danone Nutricia , Reckitt Benckiser Group plc, Abbott, Promin Metabolics, Ajinomoto Cambrooke, Inc, Promin, Som innovation biotech, SLSynthetic Biologics, Inc., Nestle,  Codexis, BioMarin, Erytech Pharma are the key market players.

Inquiry before Buying and Get 25% Instant Discount @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-phenylketonuria-pku-treatment-market

About Data Bridge Market Research:                                       

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Tags
Show More
Leave a Message
close slider

Close
Close